Cardiac Assist Devices Market Outlook (2023 to 2033)
The global cardiac assist devices market is poised to surpass US$ 1.37 billion by 2023, surging at a remarkable CAGR of 6.1% through 2033 to reach US$ 2.48 billion.
The incorporation of advanced technology such as the Internet of Thinking and rising investment from leading players results in market growth.
The technologies utilized to create cardiac devices have advanced dramatically during the past ten years, and so have the indications for these devices. Due to this, many patients are now being handled with cardiology devices, which have had exponential therapeutic and monitoring outcomes.
The development that has had a big positive effect on cardiology is artificial intelligence, which has increased diagnostic skills for some cardiac disorders.
Attributes
Details
Cardiac Assist Devices Market Estimated Value (2023)
US$ 1.37 billion
Cardiac Assist Devices Market Estimated Value (2033)
US$ 2.48 billion
Cardiac Assist Devices Market Value CAGR (2023 to 2033)
6.1% CAGR
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2018 to 2022 Global Cardiac Assist Devices Market Outlook in Comparison to 2023 to 2033 Forecast
Cardiac Assist Devices Market recorded steady growth of 5.8% CAGR during the historical period, from 2018 to 2022. The rising prevalence of heart failure across the globe resulted in increased demand for cardiac assist devices.
Technological development in the field of ventricular assist devices is recognized as a key driver for the growth of the cardiac assist devices industry with mounting cases of coronary heart diseases.
As per FMI’s analysis, growth in cardiac assist devices is attributed to the increasing prevalence of lifestyle disorders that are the main cause of cardiovascular diseases. Cardiovascular diseases such as coronary heart disease and others have led to increased cases of heart failure, especially across the United States of America, the United Kingdom, and India.
Demand for heart transplantation has significantly increased due to the rising cases of heart failure. However, the unavailability of heart donors and long waiting list result in increased mortality rates.
Patients are hence opting for ventricular assist devices for the treatment of heart failure. Due to the increased demand for ventricular assist devices, leading companies are continuously developing advanced cardiac assist devices catering to the demand. Moreover, key companies are adopting cutting-edge technologies such as artificial intelligence and the Internet of Thinking to facilitate the rising demand and curb mortality rates.
As per FMI, the market witnessed a year-on-year (Y-o-Y) growth at 6.1% CAGR, topping US$ 2.48 billion in 2033.
What is the Impact of Demand for Minimally Invasive Devices on the Market?
Integration of cutting-edge technologies such as artificial intelligence and the Internet of Things has led to technological advancements in cardiac assist devices, propelling an increase in demand.
The growing presence of robots and automated devices in operating rooms has created a need for minimally invasive devices, resulting in a surge in sales of cardiac assist devices.
State-of-the-art technologies and a rising number of patients preferring non-invasive devices have contributed to the increased demand for implantable devices. Benefits such as fast recovery and short hospital stays are driving the demand for non-invasive options.
The soaring demand has prompted key players to engage in research and development activities, focusing on innovation in cardiac assist devices.
Market players are particularly focused on developing small centrifugal pumps that enable less-invasive implantation procedures.
The adoption of minimally invasive techniques in cardiac procedures has led to a shift in the market landscape, with an emphasis on developing and improving technologies that enable less invasive interventions.
The demand for minimally invasive devices has led to improved patient outcomes, including short recovery times, reduced hospital stays, and few post-operative complications.
The increasing demand for minimally invasive devices is expected to continue driving market growth and expand treatment options for patients requiring cardiac assist devices.
Find your sweet spots for generating winning opportunities in this market.
How are the High Cost and Risk Associated with Ventricular Assist Devices Expected to Restrict Growth?
The high cost and associated risks of ventricular assist devices pose a restriction on market growth.
Patients in developing economies, such as Africa and India, are unable to afford the cost of these devices, limiting their accessibility.
While healthcare professionals highly recommend ventricular assist devices, risks such as pump thrombus, suction events, and infections present challenges for market players.
After the implantation of left ventricular assist devices (LVAD), around 60% of patients experience complications within 6 months, and 80% suffer from at least one adverse effect after a year, as reported by the European Society of Cardiology.
Unplanned hospital revisits are common for patients who have undergone LVAD transplantation, further highlighting the challenges and risks associated with these devices.
The risks represent potential threats for market players and are expected to hinder the demand for ventricular assist devices.
Comparative View of the Cardiac Assist Devices Market
Cardiac Assist Devices Market:
Attributes
Cardiac Assist Devices Market
CAGR (2023 to 2033)
6.1%
Market Value (2033)
US$ 2.48 billion
Opportunity
As healthcare infrastructure improves in developing economies, there is a growing demand for advanced medical technologies, including cardiac assist devices. By entering these markets, companies can tap into new customer bases and increase their market share.
Key Trends
Integration of remote monitoring and telemedicine capabilities allows healthcare providers to remotely monitor patients' cardiac function and device performance, enabling early detection of complications and timely intervention.
Cardiac Surgery Devices Market:
Attributes
Cardiac Surgery Devices Market
CAGR (2023 to 2033)
3.5%
Market Value (2033)
US$ 2.45 billion
Opportunity
Product launches and favorable government investments are projected to be the primary growth strategies.
Key Trends
One unique trend in the cardiac surgery devices market is the advancement of robotic-assisted cardiac surgery, allowing for small incisions, reduced trauma to the patient, and improved surgical outcomes.
Heart Closure Devices Market:
Attributes
Heart Closure Devices Market
CAGR (2023 to 2033)
14.9%
Market Value (2033)
US$ 10.88 billion
Opportunity
Increasing focus on personalized medicine and customized closure solutions and the opportunity lies in the development of heart closure devices that can be customized to fit individual patient needs.
Key Trends
A unique trend in the heart closure devices market is the development of bioresorbable closure devices, which presents an opportunity for manufacturers to provide innovative and patient-friendly solutions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Insights
Why is the United States of America Likely to Remain at the Forefront of the Cardiac Assist Devices Market?
Over the past few years, the United States of America has been in the lead in terms of healthcare. Increasing cases of cardiovascular disease contributed to the country’s market share of 51.7% in 2022.
Technological advancements in the field of cardiac assist devices are one of the key factors driving growth. The rising prevalence of heart failure within the country has increased the demand for ventricular assist devices. Furthermore, healthcare professionals and scientists are incessantly working on developing next-generation ventricular assist devices.
Thanks to the presence of leading players such as Medtronic PLC., and Abbott Laboratories, the development of cardiac assist devices and new launches, have significantly improved the market revenue.
Increasing preference for non-invasive, portable, and implantable devices has also accelerated the market growth in the country. Leading healthcare companies are developing products in the pipeline focusing on minimally invasive ventricular assist devices. For instance,
In March 2020, the United States of America-based healthcare giant, SynCardia Systems LLC, got approval from the United States of America Food and Drug Administration (FDA) for a 50cc temporary total artificial heart system as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.
With the rising incidence of cardiovascular disease in the country, the number of heart transplant surgeries is increasing at a mounting pace. However, the severe shortage of organ donors has resulted in increasing demand for heart devices. The increasing number of patients opting for cardiac assist devices in the United States of America fuels the market growth during the forecast period.
How does the Market in India Emerge as a Notable One for Cardiac Assist Devices?
As per Future Market Insights, India is anticipated to be one of the highly profitable markets of South Asia in the cardiac assist devices market with a projected CAGR of 5.1% from 2023 to 2033.
The expansion of the healthcare sector and the development of ventricular assist devices are affecting the market growth positively. The prevalence of heart failure in the country has resulted in increased demand for cardiac assist devices. Additionally, increased government funding and initiatives for the development of healthcare facilities are likely to boost growth across India.
India is the top country with a high diabetic population, and nearly 77 million people suffer from diabetes, estimates International Diabetes Federation. Diabetes is the primary cause of developing major heart disease. One-fifth of the Indian population succumb due to coronary heart disease.
India is witnessing a simultaneous uptick in the number of heart failure, especially among the younger population due to the rising cases of coronary heart disease. With the increasing burden of heart failure in the country, patients are opting for minimally invasive procedures. This, in turn, has increased the demand for ventricular assist devices, especially left ventricular assist devices in India.
Growing government funding and initiatives are also aiding the growth of the cardiac assist devices market. For instance, the Government of Assam Health and Family Welfare has introduced a scheme in which government bears the expenses of surgery for children with coronary heart disease.
What are the Factors Driving Revenue Generation in the United Kingdom Market?
Growth in the United Kingdom for cardiac assist devices is attributable to the increasing technological advancements in the field of ventricular assist devices, where the United Kingdom garnered a revenue share of 6.4% in 2022.
With the rising prevalence of coronary heart diseases resulting in heart failure, the adoption of ventricular assist devices is improving. Furthermore, the expansion of healthcare infrastructure and leading companies focusing on the development of next-generation cardiac assist devices have improved the adoption of ventricular assist devices.
Leading player based in the United Kingdom, Calon Cardio-Technology, for instance, intends to receive CE marking fulfilling the European products requirement for its ventricular assist device, commonly known as, MiniVAD.
Increasing investment in the development of these devices is creating incremental opportunities for cardiac assist devices in the country. With patients now opting for minimally invasive devices for the treatment of heart failure, demand for ventricular assist devices is burgeoning across the United Kingdom.
What Factors Support the Growth of Cardiac Assist Devices in Germany?
As per Future Market Insights, Germany is anticipated to lead the growth of Europe’s cardiac assist market, holding a value share of 11.2% in 2022 globally.
Technological advancements and innovation in ventricular assist devices are key growth factors driving the demand for cardiac assist devices in Germany. Moreover, companies are investing hugely in the development of cardiac assist devices to cater to the increasing demand.
Increasing initiatives and funding from the government are also aiding the growth of the cardiac assist devices market in Germany. Further, leading players such as Biotronik, are developing next-generation implantable and ventricular assist devices for patients suffering from heart failure.
In July 2021, BIOTRONIK’s implantable cardiac monitor received recognition as a high-performing noiseless, and high-precision technology.
Category-wise Insights
Why is the Demand for Ventricular Assist Devices (VAD) Rising?
Accounting for over 62.49% of global revenue share, ventricular assist devices are anticipated to be highly sought-after in the cardiac assist devices industry. Increasing demand for left ventricular assist devices in aiding the growth of VAD.
Future Market Insights estimates VAD to be the product of choice in the market. As healthcare professionals and engineers are developing next-generation devices fully implantable on both sides of the heart, ventricular assist devices are expected to gain traction.
Growth in this segment is attributed to technological advancements, the rising prevalence of cardiac arrest, and the shortage of organ donors. Also, advancements and upgradation in the development of LVAD have bolstered its adoption.
Leading healthcare companies such as Abbott Laboratories, Medtronic PLC, and Abiomed are increasing research activities to develop advanced LVAD catering to the rising demand. With rapid development, companies are seeking fast-track approvals from regulatory bodies which are resulting in high investment.
With the increasing demand for technologically updated ventricular assist devices, the market is expected to register high demand in the next decade.
Why are Implantable Devices Gaining Popularity in Cardiac Assist Devices Market?
Based on modality type, the market is segmented into transcutaneous and implantable cardiac assist devices. As per Future Market Insights, the implantable devices segment captured a share of 60.79% in 2022.
Owing to the benefits of the ability to screen, monitor, and control erratic heart rhythms, implantable devices are expected to gain immense popularity during the forecast period. Moreover, the rising need for efficient solutions to manage heart failure is predicted to improve the adoption of implantable devices. Additionally, increasing preference for non-invasive surgical procedures has accelerated the adoption of implantable devices.
An implantable cardioverter defibrillator is a useful device that helps prevent sudden death in patients suffering from sustained ventricular tachycardia or fibrillation. Technological advancements and gradation in implantable cardiac assist devices have improved the demand.
How are Hospital Pharmacies Gaining Popularity as the Primary End-User?
Hospital pharmacies are gaining popularity as the primary end-user in the healthcare industry due to several reasons that are contributing to the sub-segment share of 79.8% in 2022.
Firstly, hospital pharmacies offer a centralized and convenient source of medication procurement and distribution within the hospital setting. This ensures efficient inventory management, reduces medication errors, and improves patient safety.
Secondly, hospital pharmacies provide specialized pharmaceutical services, including compounding, drug information, and medication management, tailored to the unique needs of the hospital and its patients.
Lastly, with the increasing complexity of medication therapies and the need for close collaboration with healthcare providers, hospital pharmacies play a vital role in ensuring optimal patient outcomes and medication utilization.
How is the Competitive Landscape in the Cardiac Assist Devices Industry Structured?
As per FMI’s analysis, continuous innovation and gradation in cardiac assist devices have led to intense competition among top market players.
Key players are focusing on new product launches and gaining approvals from regulatory bodies to stay in the competition. Nearly 75% of the global market share is accounted for by the top 7 players operating in the cardiac assist devices market.
Organizations are also adopting winning strategies such as collaborations and mergers among key players. These strategies are also adopted by regional players to gain a leading position in the industry.
Key Players Operating in the Market
Terumo Corporation
Medtronic PLC
Abbott Laboratories
Abiomed Inc.
Teleflex Incorporated
Maquet GmbH
BerlinHeart GmbH
Others
Developments in the Market:
In June 2021, Abbott Laboratories announced that the company can support the expanded use of a mechanical circulatory support device, HEARTMATE 3™ Heart Pump, for the effective treatment of heart failure.
In February 2021, CARMAT, the leading designer and developer of the world’s most advanced artificial heart, received approval from the United States of America Food and Drugs Administration (FDA) to use the new version of its artificial heart in the US Early Feasibility Study (EFS).
Market by Category
By Product Type:
Ventricular Assist Devices (VAD)
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
External Ventricular Assist Devices
Intra-Aortic Balloon Pump
By Modality Type:
Transcutaneous
Implantable
By End User:
Hospital
Ambulatory Surgical Centers
By Region:
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Japan
The Middle East & Africa (MEA)
Frequently Asked Questions
The cardiac assist devices market value reaches US$ 1.37 billion in 2023.
The cardiac assist devices market is anticipated to surpass US$ 2.48 billion by 2033, recording a CAGR of 6.1%.
The implantable cardiac assist devices segment is likely to gain prominence, holding 60.79% of market revenue.
The United States boasts lucrative potential for cardiac assist devices with advanced healthcare infrastructure and increasing cardiovascular conditions.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Ventricular Assist Devices (VAD)
5.3.1.1. Left Ventricular Assist Device (LVAD)
5.3.1.2. Right Ventricular Assist Device (RVAD)
5.3.1.3. Biventricular Assist Device (BIVAD)
5.3.1.4. External Ventricular Assist Devices
5.3.2. Intra-Aortic Balloon Pump
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Modality Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality Type, 2023 to 2033
6.3.1. Transcutaneous
6.3.2. Implantable
6.4. Y-o-Y Growth Trend Analysis By Modality Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Modality Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033
7.3.1. Hospital
7.3.2. Ambulatory Surgical Centers
7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Modality Type
9.2.4. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Modality Type
9.3.4. By End-User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Modality Type
10.2.4. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Modality Type
10.3.4. By End-User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product Type
11.2.3. By Modality Type
11.2.4. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Modality Type
11.3.4. By End-User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product Type
12.2.3. By Modality Type
12.2.4. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Modality Type
12.3.4. By End-User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product Type
13.2.3. By Modality Type
13.2.4. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Modality Type
13.3.4. By End-User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product Type
14.2.3. By Modality Type
14.2.4. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Modality Type
14.3.4. By End-User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Modality Type
15.2.4. By End-User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Modality Type
15.3.4. By End-User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Modality Type
16.1.2.3. By End-User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Modality Type
16.2.2.3. By End-User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Modality Type
16.3.2.3. By End-User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Modality Type
16.4.2.3. By End-User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Modality Type
16.5.2.3. By End-User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Modality Type
16.6.2.3. By End-User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Modality Type
16.7.2.3. By End-User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Modality Type
16.8.2.3. By End-User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Modality Type
16.9.2.3. By End-User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Modality Type
16.10.2.3. By End-User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Modality Type
16.11.2.3. By End-User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Modality Type
16.12.2.3. By End-User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Modality Type
16.13.2.3. By End-User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Modality Type
16.14.2.3. By End-User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Modality Type
16.15.2.3. By End-User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Modality Type
16.16.2.3. By End-User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Modality Type
16.17.2.3. By End-User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Modality Type
16.18.2.3. By End-User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Modality Type
16.19.2.3. By End-User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Modality Type
16.20.2.3. By End-User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Modality Type
16.21.2.3. By End-User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product Type
16.22.2.2. By Modality Type
16.22.2.3. By End-User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product Type
16.23.2.2. By Modality Type
16.23.2.3. By End-User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Modality Type
17.3.4. By End-User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Terumo Corporation
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Medtronic PLC
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Abbott Laboratories
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Abiomed Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Teleflex Incorporated
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Maquet GmbH
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. BerlinHeart GmbH
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Western Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 15: Western Europe Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 16: Western Europe Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 20: Eastern Europe Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 26: East Asia Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 27: East Asia Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 28: East Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Modality Type, 2018 to 2033
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by End-User, 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033
Figure 18: Global Market Attractiveness by Modality Type, 2023 to 2033
Figure 19: Global Market Attractiveness by End-User, 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033
Figure 38: North America Market Attractiveness by Modality Type, 2023 to 2033
Figure 39: North America Market Attractiveness by End-User, 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Modality Type, 2023 to 2033
Figure 59: Latin America Market Attractiveness by End-User, 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Western Europe Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 62: Western Europe Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 63: Western Europe Market Value (US$ Million) by End-User, 2023 to 2033
Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Western Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 71: Western Europe Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 74: Western Europe Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 77: Western Europe Market Attractiveness by Product Type, 2023 to 2033
Figure 78: Western Europe Market Attractiveness by Modality Type, 2023 to 2033
Figure 79: Western Europe Market Attractiveness by End-User, 2023 to 2033
Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Eastern Europe Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 82: Eastern Europe Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 83: Eastern Europe Market Value (US$ Million) by End-User, 2023 to 2033
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 97: Eastern Europe Market Attractiveness by Product Type, 2023 to 2033
Figure 98: Eastern Europe Market Attractiveness by Modality Type, 2023 to 2033
Figure 99: Eastern Europe Market Attractiveness by End-User, 2023 to 2033
Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: South Asia and Pacific Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 102: South Asia and Pacific Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 103: South Asia and Pacific Market Value (US$ Million) by End-User, 2023 to 2033
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 117: South Asia and Pacific Market Attractiveness by Product Type, 2023 to 2033
Figure 118: South Asia and Pacific Market Attractiveness by Modality Type, 2023 to 2033
Figure 119: South Asia and Pacific Market Attractiveness by End-User, 2023 to 2033
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033
Figure 121: East Asia Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 122: East Asia Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 123: East Asia Market Value (US$ Million) by End-User, 2023 to 2033
Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 128: East Asia Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 131: East Asia Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 134: East Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 135: East Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 137: East Asia Market Attractiveness by Product Type, 2023 to 2033
Figure 138: East Asia Market Attractiveness by Modality Type, 2023 to 2033
Figure 139: East Asia Market Attractiveness by End-User, 2023 to 2033
Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 141: Middle East and Africa Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 142: Middle East and Africa Market Value (US$ Million) by Modality Type, 2023 to 2033
Figure 143: Middle East and Africa Market Value (US$ Million) by End-User, 2023 to 2033
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Modality Type, 2018 to 2033
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Modality Type, 2023 to 2033
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Modality Type, 2023 to 2033
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 157: Middle East and Africa Market Attractiveness by Product Type, 2023 to 2033
Figure 158: Middle East and Africa Market Attractiveness by Modality Type, 2023 to 2033
Figure 159: Middle East and Africa Market Attractiveness by End-User, 2023 to 2033
Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
